S

Director Director DIN 06396370
DIN 06396370 First appointment May 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2013
Shareholding value •••• Premium profile

About Sandeep

Data last updated:

Sandeep was a Director at Bovetas Pharmaceuticals Private Limited (2013–2023) and Director at Drodev Infrastructure Private Limited (2023–2024). The companies operate in Chemicals and Fabrication.

DIN 06396370
Primary Designation Director
Industry Chemicals
First Appointment 03 May 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 May 20132013₹45,000 (FY 2019)Active
Director05 Sep 20232021₹19 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bovetas Pharmaceuticals Private Limited
Drodev Infrastructure Private Limited
Premium access

Shareholding and investment profile for Sandeep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep

Sandeep was first appointed on 03 May 2013 as Director at Bovetas Pharmaceuticals Private Limited. The most recent appointment on record is 05 Sep 2023 at Drodev Infrastructure Private Limited.

Sandeep held 2 earlier board appointments: Bovetas Pharmaceuticals Private Limited (Director, 03 May 2013 to 30 Mar 2023); Drodev Infrastructure Private Limited (Director, 05 Sep 2023 to 08 Nov 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available